Osteoporosis Drug Market Report: Trends, Forecast

Spread the love

The Osteoporosis Drugs Global Market Report 2023 by The Business Research Company, provides osteoporosis drugs market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Osteoporosis Drugs Market:

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

According to The Business Research Company’s Osteoporosis Drugs Global Market Report 2023, the market size is expected to grow from$13.79 billion in 2022 to $14.60 billion in 2023 at a compound annual growth rate (CAGR) of 5.84%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global osteoporosis drugs market size is expected to reach $17.58 billion in 2027 at a CAGR of 4.7%.

A surge in the prevalence of osteoporosis is expected to propel the growth of the osteoporosis drug market. Osteoporosis is a bone disease that occurs when bone mineral density and mass bone decline or when bone quality or structure changes. People who have a low calcium intake are more likely to develop osteoporosis. These osteoporosis drugs increase bone mineral density and help to prevent fractures.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=9102&type=smp

The osteoporosis drugs market is segmented:

1) By ype: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors

2) By Administration: Oral, Injectable

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales

4) By Application: Primary Osteoporosis, Secondary Osteoporosis

Product innovations have emerged as a key trend gaining popularity in the osteoporosis drugs market. Major companies operating in the market are advancing toward the use of innovative solutions for the osteoporosis drug market. For instance, in January 2020, Zobrius Pharma, a Norway-based developer of unique health supplements, launched Maxx-Calzium, a new nutritional supplement. It provides an alternative to the inorganic calcium found in limestone that is typically included in dietary supplements. This new product’s major ingredient is eggshell calcium from Norilia, together with vitamin D3 and vitamin K2, which can help the body absorb calcium.

The osteoporosis drugs market report table of contents includes: